This study examines how well high-intensity focused ultrasound ablation works in treating patients with prostate cancer. High-intensity focused ultrasound ablation may target individual area of prostate tissue, while preserving the majority of prostate tissue and minimizing damage to surrounding structures.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03620786.
Locations matching your search criteria
United States
California
Los Angeles
UCLA / Jonsson Comprehensive Cancer CenterStatus: Active
Contact: Leonard S Marks
Phone: 310-794-3099
PRIMARY OBJECTIVE:
I. To evaluate the efficacy and safety of the sonablate high-intensity focused ultrasound (HIFU) system in the ablation of prostate tissue using magnetic resonance imaging (MRI)-ultrasound fusion for guidance.
OUTLINE:
Patients' medical charts are reviewed for approximately 2 years from the date of the HIFU procedure. Patients may complete questionnaires over 5-10 minutes at routine follow- up appointments about urinary and erectile function.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationUCLA / Jonsson Comprehensive Cancer Center
Principal InvestigatorLeonard S Marks
